The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma

Iris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, Scott Wilhelm, Patrick J Hayden, Kenneth C Anderson, Marc S Raab

Research output: Journal article (peer-reviewed)Journal article

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science